Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.58 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.54 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.54 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.54 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.54 |
| ▸ | ALPI | P09923 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | XIAP | P98170 | 1/20 | 0.54 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.53 |
| ▸ | LAP3 | P28838 | 3/20 | 0.50 |
| ▸ | ANPEP | P15144 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8482921 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL14719648 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL6931887 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL6446300 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL9740410 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL6445044 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL6929688 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL7144488 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL6446370 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL7168775 | 1.00 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9139515-B2 | Synthesis of R-biphenylalaninol | DPX HOLDINGS B.V. (US) | 2015-09-22 | — | — | US | disclosed |
| US-20140296559-A1 | SYNTHESIS OF R-BIPHENYLALANINOL | DSM FINE CHEMICALS AUSTRIA NFG. GMBH & CO KG (AT) | 2014-10-02 | — | — | US | disclosed |
| EP-2744779-A1 | SYNTHESIS OF R-BIPHENYLALANINOL | DSM IP Assets B.V. (NL) | 2014-06-25 | — | — | EP | disclosed |
| WO-2013026773-A1 | SYNTHESIS OF R-BIPHENYLALANINOL | DSM IP ASSETS B.V. (NL) | 2013-02-28 | — | — | WO | disclosed |
| US-6667404-B2 | Carbamylation of 1-amino group of 1,4-amino-3-hydroxybutane derivative with an organocarbonate containing thiazolyl, oxazolyl, isoxazolyl or isothiazolyl substituent | ABBOTT LABORATORIES | 2003-12-23 | — | — | US | disclosed |
| US-5679797-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296559-A1 | SYNTHESIS OF R-BIPHENYLALANINOL | CYP2B6, CYP2A6, CYP2D6 | EPHX1 725/4885SLC15A1 3006/4885SLC6A2 752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.